-
Je něco špatně v tomto záznamu ?
The ESX-5 System of Pathogenic Mycobacteria Is Involved In Capsule Integrity and Virulence through Its Substrate PPE10
LS. Ates, AD. van der Woude, J. Bestebroer, G. van Stempvoort, RJ. Musters, JJ. Garcia-Vallejo, DI. Picavet, Rv. Weerd, M. Maletta, CP. Kuijl, NN. van der Wel, W. Bitter,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Free Medical Journals od 2005
Public Library of Science (PLoS) od 2005
PubMed Central od 2005
Europe PubMed Central od 2005
ProQuest Central od 2005-09-01
Open Access Digital Library od 2005-09-01
Open Access Digital Library od 2005-01-01
Open Access Digital Library od 2005-01-01
Medline Complete (EBSCOhost) od 2005-09-01
Health & Medicine (ProQuest) od 2005-09-01
ROAD: Directory of Open Access Scholarly Resources od 2005
Odkazy
PubMed
27280885
DOI
10.1371/journal.ppat.1005696
Knihovny.cz E-zdroje
- MeSH
- atypické mykobakteriální infekce metabolismus MeSH
- bakteriální pouzdra metabolismus MeSH
- buněčné linie MeSH
- chromatografie na tenké vrstvě MeSH
- dánio pruhované MeSH
- elektronová mikroskopie MeSH
- faktory virulence metabolismus MeSH
- imunoblotting MeSH
- lidé MeSH
- modely nemocí na zvířatech MeSH
- Mycobacterium marinum metabolismus patogenita MeSH
- průtoková cytometrie MeSH
- sekreční systém typu VII metabolismus MeSH
- virulence fyziologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Mycobacteria produce a capsule layer, which consists of glycan-like polysaccharides and a number of specific proteins. In this study, we show that, in slow-growing mycobacteria, the type VII secretion system ESX-5 plays a major role in the integrity and stability of the capsule. We have identified PPE10 as the ESX-5 substrate responsible for this effect. Mutants in esx-5 and ppe10 both have impaired capsule integrity as well as reduced surface hydrophobicity. Electron microscopy, immunoblot and flow cytometry analyses demonstrated reduced amounts of surface localized proteins and glycolipids, and morphological differences in the capsular layer. Since capsular proteins secreted by the ESX-1 system are important virulence factors, we tested the effect of the mutations that cause capsular defects on virulence mechanisms. Both esx-5 and ppe10 mutants of Mycobacterium marinum were shown to be impaired in ESX-1-dependent hemolysis. In agreement with this, the ppe10 and esx5 mutants showed reduced recruitment of ubiquitin in early macrophage infection and intermediate attenuation in zebrafish embryos. These results provide a pivotal role for the ESX-5 secretion system and its substrate PPE10, in the capsular integrity of pathogenic mycobacteria. These findings open up new roads for research on the mycobacterial capsule and its role in virulence and immune modulation.
Department of Molecular Microbiology VU University Amsterdam the Netherlands
Department of Physiology and Cardiology VU University Medical Center Amsterdam the Netherlands
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023922
- 003
- CZ-PrNML
- 005
- 20170908124946.0
- 007
- ta
- 008
- 170720s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.ppat.1005696 $2 doi
- 035 __
- $a (PubMed)27280885
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Ates, Louis S $u Department of Medical Microbiology and Infection Prevention, VU University Medical Center, Amsterdam, the Netherlands. $7 gn_A_00009731
- 245 14
- $a The ESX-5 System of Pathogenic Mycobacteria Is Involved In Capsule Integrity and Virulence through Its Substrate PPE10 / $c LS. Ates, AD. van der Woude, J. Bestebroer, G. van Stempvoort, RJ. Musters, JJ. Garcia-Vallejo, DI. Picavet, Rv. Weerd, M. Maletta, CP. Kuijl, NN. van der Wel, W. Bitter,
- 520 9_
- $a Mycobacteria produce a capsule layer, which consists of glycan-like polysaccharides and a number of specific proteins. In this study, we show that, in slow-growing mycobacteria, the type VII secretion system ESX-5 plays a major role in the integrity and stability of the capsule. We have identified PPE10 as the ESX-5 substrate responsible for this effect. Mutants in esx-5 and ppe10 both have impaired capsule integrity as well as reduced surface hydrophobicity. Electron microscopy, immunoblot and flow cytometry analyses demonstrated reduced amounts of surface localized proteins and glycolipids, and morphological differences in the capsular layer. Since capsular proteins secreted by the ESX-1 system are important virulence factors, we tested the effect of the mutations that cause capsular defects on virulence mechanisms. Both esx-5 and ppe10 mutants of Mycobacterium marinum were shown to be impaired in ESX-1-dependent hemolysis. In agreement with this, the ppe10 and esx5 mutants showed reduced recruitment of ubiquitin in early macrophage infection and intermediate attenuation in zebrafish embryos. These results provide a pivotal role for the ESX-5 secretion system and its substrate PPE10, in the capsular integrity of pathogenic mycobacteria. These findings open up new roads for research on the mycobacterial capsule and its role in virulence and immune modulation.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a bakteriální pouzdra $x metabolismus $7 D016667
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a chromatografie na tenké vrstvě $7 D002855
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a průtoková cytometrie $7 D005434
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunoblotting $7 D015151
- 650 _2
- $a elektronová mikroskopie $7 D008854
- 650 _2
- $a atypické mykobakteriální infekce $x metabolismus $7 D009165
- 650 _2
- $a Mycobacterium marinum $x metabolismus $x patogenita $7 D019910
- 650 _2
- $a sekreční systém typu VII $x metabolismus $7 D000069377
- 650 _2
- $a virulence $x fyziologie $7 D014774
- 650 _2
- $a faktory virulence $x metabolismus $7 D037521
- 650 _2
- $a dánio pruhované $7 D015027
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a van der Woude, Aniek D $u Department of Medical Microbiology and Infection Prevention, VU University Medical Center, Amsterdam, the Netherlands. Department of Molecular Microbiology, VU University, Amsterdam, the Netherlands.
- 700 1_
- $a Bestebroer, Jovanka $u Department of Medical Microbiology and Infection Prevention, VU University Medical Center, Amsterdam, the Netherlands.
- 700 1_
- $a van Stempvoort, Gunny $u Department of Molecular Microbiology, VU University, Amsterdam, the Netherlands.
- 700 1_
- $a Musters, René J P $u Department of Physiology and Cardiology, VU University Medical Center, Amsterdam, the Netherlands.
- 700 1_
- $a Garcia-Vallejo, Juan J $u Department of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, the Netherlands.
- 700 1_
- $a Picavet, Daisy I $u Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam the Netherlands.
- 700 1_
- $a Weerd, Robert van de $u Department of Medical Microbiology and Infection Prevention, VU University Medical Center, Amsterdam, the Netherlands.
- 700 1_
- $a Maletta, Massimiliano $u Eyen SE, Prague, Czech Republic.
- 700 1_
- $a Kuijl, Coenraad P $u Department of Medical Microbiology and Infection Prevention, VU University Medical Center, Amsterdam, the Netherlands.
- 700 1_
- $a van der Wel, Nicole N $u Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam the Netherlands.
- 700 1_
- $a Bitter, Wilbert $u Department of Medical Microbiology and Infection Prevention, VU University Medical Center, Amsterdam, the Netherlands. Department of Molecular Microbiology, VU University, Amsterdam, the Netherlands.
- 773 0_
- $w MED00008922 $t PLoS pathogens $x 1553-7374 $g Roč. 12, č. 6 (2016), s. e1005696
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27280885 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170908125548 $b ABA008
- 999 __
- $a ok $b bmc $g 1239603 $s 984835
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 12 $c 6 $d e1005696 $e 20160609 $i 1553-7374 $m PLOS pathogens $n PLoS Pathog $x MED00008922
- LZP __
- $a Pubmed-20170720